Psychedelics and Cannabis in the Next Military Defense Budget? Why It Matters

Psychedelics and Cannabis in the Next Military Defense Budget? Why It Matters

In this post:

  • Psychedelics (and cannabis) are Still Federally Banned
  • Bi-partisan Support for Psychedelics Grows
  • Hope for the Future of Legalization

No one pays the cost of war more than US service members. In fact, 2021 research showed that military personnel are four times more likely to die by suicide than in combat.

Rep. Dan Crenshaw (R-TX) and Alexandria Ocasio-Cortez (D-NY) seek to change that reality. In July, Crenshaw proposed an amendment to the National Defense Authorization Act for 2023, granting federal funding for psychedelic therapy for active duty members. His list of proposed substances included MDMA, psilocybin, ibogaine, and 5–MeO–DMT.  Alexandria Ocasio-Cortez’s (AOC) amendment added psilocybin and MDMA to the list of substances (including cannabis) to study as opioid alternatives.

The House of Representatives approved both amendments, which means the Senate will weigh in next. In the meantime, let’s look at what these proposals entail and what they could mean for the future of federal drug reform.

Psychedelics (and Cannabis) are Still Federally Banned

All compounds on Crenshaw and AOC’s amendments, like psilocybin mushrooms, cannabis, MDMA, ibogaine, and 5-MeO-DMT, are all classified as Schedule 1 controlled substances. The DEA defines Schedule I drugs as chemicals with “no accepted medical use and a high potential for abuse,”

Fortunately, leading government officials aren’t buying into the DEA’s classification system anymore. And mass media publications are shifting narratives to display plant medicines in a more honest light.

Mainstream powers are beginning to acknowledge that most psychedelics, especially classical psychedelics, like mushrooms and LSD,  aren’t addictive. They don’t create psychological cravings, so they don’t have a high potential for abuse. More importantly, they exhibit significant healing potential.

URL - ACS Contact Banner - Click to Send an Email

Bi-Partisan Support for Psychedelics Grows

Adding proof to the concept, the Federal Drug Administration (FDA) designated MDMA and magic mushrooms as “breakthrough therapies” for PTSD and major depressive disorders. While this designation does not mean these substances are FDA-approved, it does ease the way for clinical trials while putting the DEA’s designation in a precarious spot.  Notably, the FDA’s findings set the stage for rational debate amongst lawmakers on both sides of the aisle.

As a politically neutral organization, the FDA’s psychedelic support helps ease partisan tensions, ensuring the issue isn’t left vs. right. Instead, it’s a neutral movement to alleviate suffering for military members who have made immense sacrifices.

Today, both sides of the political spectrum are pushing for these critical reforms. Led by Republican Dan Crenshaw and Democrat AOC, liberals and conservatives both want service members to have safe, effective alternatives to addictive and even deadly pharmaceuticals.

Hope for the Future of Legalization

Last year, congress put forth similar psychedelic amendments, but they never made it to the floor. Fortunately, Crenshaw has consistently spoken out on this topic, urging his colleagues to rethink preconceived notions about psychedelics.

“Many hear the word ‘psychedelics,’ and they think of acid trips from the ’60s,” he said. “We’re talking about the proven use of psychedelics to treat PTSD.”

“All I’m asking is that we give our service members the ability to access this treatment instead of forcing them to travel abroad to psychedelic clinics to save their own life.”

As a result of Crenshaw and AOC’s consistent advocacy, the chamber voted favorably this year. If passed by the Senate, AOC’s amendment could prevent thousands of opioid overdose deaths. Crenshaw's amendment could help people with PTSD find hope for a new life. These studies are essential to building on current psychedelic research across the scientific community.

The Bottom Line

Moving psychedelic mushrooms, cannabis, MDMA, ibogaine, and 5-MeO-DMT out of the Schedule 1 list won’t happen overnight–even if the Senate approves these defense spending amendments. Still, bipartisan federal legislation is another sign that the psychedelic renaissance is underway.

Whether it’s politicians like Rep. Crenshaw or AOC, psychedelic research organizations like MAPS, or academic research institutions like Johns Hopkins University, good people and renowned organizations support this cause. Our ACS Laboratory team is one of those advocates.

At ACS Laboratory, we’re excited about the future and look forward to being one of the first laboratories to advance the field of psychedelics for analytical testing.

URL - ACS Contact Banner - Click to Send an Email

The Cannabinoids Guide

This complete cannabinoid guide covers major and minor cannabinoids, how they work in the body, and highlights the top compounds brands and operators must test for today.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

The Cannabinoid Guide

The definitive resource on leading major and minor cannabinoids, how they work in the body, and what to test for.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Related Blogs

March 20, 2023

Terpene Tuesdays: Everything You Need to Know About Sabinene Hydrate Flavor, Fragrance, and Benefits

Sabinene Hydrate is a vital component of various plant essential oils, including cannabis. It displays antioxidant, anti-inflammatory and antimicrobial uses.

Elena Schmidt

March 23, 2023

Flavonoid Friday: Everything You Need to Know About Vitexin Flavor, Fragrance, and Benefits

Vitexin fans praise it for everything from benefiting the brain and heart to fighting diabetes and helping maintain healthy blood sugar levels.

Elena Schmidt

March 15, 2023

Understanding Amanita Pantherina Mushrooms: Appearance, Effects, and Legality

The Amanita pantherina, or the Panther Cap, is a relative of the Amanita muscaria mushroom. Its cap features ochre brown dots with white spots. It's a delirium rather than a psychedelic, and it's legal!

Masha Ty

December 16, 2022

Amanita Muscaria (Fly Agaric): History & Toxicology of the Most Misunderstood Mushroom

Amanita mushrooms are fully legal in the United States and have a long history of use. Discovery Amanita mythology and toxicology in this ACS blog.

Masha Ty

January 19, 2023

Amanita Muscaria Part II: Active Ingredients, Effects, Nutrition & Legality

Exploring amanita muscaria’s psychoactive effects, toxic potential, edible preparation, and legality in the US and Canada.

Masha Ty

March 7, 2023

Terpene Tuesdays: Everything You Need to Know About Valencene Flavor, Fragrance, and Benefits

Valencene is a rare terpene found in cannabis. It exudes an herbaceous, sweet citrus aroma with woodsy notes and is abundant in citrus fruits.

Elena Schmidt

January 25, 2023

Comparing Exotic Cannabinoids: Delta-9 THC vs. Delta-8, Delta-10, HHC, HHCP, THC-O (THCOa), & THCP

The main difference between exotic cannabinoids and Delta-9 THC is their molecular structures, psychoactive intensity, and legality.

Elena Schmidt

February 24, 2023

Flavonoid Friday: Everything You Need to Know About Orientin Flavor, Fragrance, and Benefits

Orientin is a flavonoid prevalent in cannabis, bamboo leaves, and various teas is. Its impact as an antioxidant extends into numerous human therapeutic benefits.

Elena Schmidt

February 20, 2023

Terpene Tuesdays: Everything You Need to Know About Ocimene Flavor, Fragrance, and Benefits

As a cannabis terpene, ocimene offers strains potential therapeutic benefits, including anti-viral, anti-seizure, and anti-inflammation.

Elena Schmidt

Elena Schmidt

June 13, 2019

Hemp/CBD in Florida

ACS Admin

February 17, 2023

DEA Says Delta-8 and Delta-9 THCOA (aka THCO) Falls Under Controlled Substances Act, not Farm Bill

According to the DEA's interpretation of the law, THCOA doesn’t fall within the Farm Bill's definition of hemp because hemp plants don’t naturally produce the cannabinoid.

Elena Schmidt

December 8, 2022

Companies Producing Edibles Containing CBD and Delta-8 THC Receive New Warning Letters from the FDA

FDA recently issued new warning letters to companies that produce CBD and Delta-8 THC edibles.

December 9, 2022

INTERVIEW: Live Rosin Delta-8: How It's Made, Effects, Safety & Quality

Live rosin delta 8 is a cannabis concentrate made from frozen plant material and manufactured delta-8 extract. Learn more.

December 14, 2022

Visit the New and Improved ACS Laboratory Website

Enhanced education, intuitive navigation, mushroom program launch, compliance updates, and more!

Elena Schmidt

December 20, 2022

Terpene Tuesdays: Everything You Need to Know About Camphene Flavor, Fragrance, and Benefits

Research suggests that camphene possesses anti-microbial and antiviral properties, provides coughing relief, and may even be able to prevent heart disease.

Elena Schmidt

Elena Schmidt

January 30, 2023

ACS Laboratory Receives 82 Emerald Badges for Exemplary Hemp and Cannabis Test Results, More Than Any Laboratory in the USA

Recently Awarded 21 Emerald Test Proficiency Badges for 2022, ACS has Reaffirmed its Position as the Most Trusted Third-party Hemp and Cannabis Testing Provider

ACS Laboratory

January 5, 2023

Functional Mushrooms: Exploring Lion’s Mane, Cordyceps, and Reishi Benefits & Uses

Reviewing functional mushroom benefits, research, and top products, with a focus on reishi, lion’s mane, and cordyceps.

Masha Ty